Rethinking Clinical Trials

DECEMBER 20, 2023

Globally cardiovascular disease (CVD) prevalence had decreased between 1990 and 2010, but it has slightly increased since 2010. CVD is the leading cause of mortality in women. There are several strategies that will help increase diversity in CVD trials. years for males and 5.5 years for females at age 45 years or older.

Clinical Trials 173

Clinical Trials Clinical Trials Trials Cardiology 173

Rethinking Clinical Trials

SEPTEMBER 22, 2022

Another trial is called NUDGE-DM using the same system for identifying patients with diabetes to test communication strategies for optimizing the use of guideline directed medical therapy for T2D patients with established CVD. Discussion Themes. -I I was struck by the number of people that were approached and joined the DANFLU study.

Trials 130

Trials Cardiology Vaccination Vaccine 130

Delveinsight

JULY 22, 2020

CVD & Heart Related Diseases. The hospital inventory is equipped with tagged sensors. Similarly, if some patients are brought in emergency care, the doctor can track the patient’s past medical record from the database and can start treatment without losing any time. IoT and its applications in healthcare.

Doctors 59

Doctors Doctor Marketing Production 59